The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
Open accessAbstract
Alzheimer disease (AD) is the most common cause of dementia in people over 60 years old. The molecular and cellular alterations that trigger this disease are still diffuse, one of the reasons for the delay in finding an effective treatment. In the search for new targets to search for novel therapeutic avenues, clinical studies in patients who used anti-inflammatory drugs indicating a lower incidence of AD have been of value to support the neuroinflammatory hypothesis of the neurodegenerative processes and the role of innate immunity in this disease. Neuroinflammation appears to occur as a consequence of a series of damage signals, including trauma, infection, oxidative agents, redox iron, oligomers of τ and β-amyloid, etc. In this context, our theory of Neuroimmunomodulation focus on the link between neuronal damage and brain inflammatory process, mediated by the progressive activation of astrocytes and microglial cells with the consequent overproduction of proinflammatory agents. Here, we discuss about the role of microglial and astrocytic cells, the principal agents in neuroinflammation process, in the development of neurodegenerative diseases such as AD. In this context, we also evaluated the potential relevance of natural anti-inflammatory components, which include curcumin and the novel Andean Compound, as agents for AD prevention and as a coadjuvant for AD treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it remains unclear whether microglial activation is a primary triggering mechanism or merely a consequence of protein aggregate accumulation [60]”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Alzheimer’s disease, neuroinflammation is primarily thought to be a consequence of a series of damage signals including trauma, oxidation, oligomers of Aβ and tau, and more [67].”
From Age, sex and Alzheimer’s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer’s patients (2024) · cites this paper as [67]
Experimental — accuracy not yet measuredIn the citing paper
“Pro-inflammatory cytokines and chemokines secreted into the immediate neurological environment accelerate neuronal injury and eventually neuron death (Aktas et al., 2007; Heckmann et al., 2018; Morales et al.,2014).”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Morales et al.,2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Aggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,139
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis
Christopherson, K. S., Ullian, E. M., Stokes, C. C. A., Mullowney, C. E., Hell, J. W., Agah, A., Lawler, J., Mosher, D. F., Bornstein, P., & Barres, B. A. (2005) · Cell · doi:10.1016/j.cell.2004.12.020 · Cited by 1,688
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“Even in mice, NSAIDs directly affect the development of amyloid in the brain, reducing Aβ-42 peptide levels (Weggen et al., 2001).”
Background
Flagged first, then by citations
Research works printed but not linked: 1
- Powell, 1999, Dissection of astrocyte-mediated cues in neuronal guidance and process extension, Glia, 26, 73, 10.1002/(sici)1098-1136(199903)26:173::aid-glia83.0.co;2-s · DOI
Cited by
Sorted by citations
Items 401–500 of 504
Luo, Q., Hu, W., Yu, H.-F., Zhang, R., & Chen, X. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4376812 · Cited by 4
Kabra, A. (2022) · International journal of high school research · doi:10.36838/v4i6.10 · Cited by 4
Neuroinflammation in Alzheimer’s Disease
Kaity, S., & Kumar, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_3 · Cited by 4
Neuroimmune Dynamics in Alzheimer’s Disease Progression
Andrade, V., Guzmán‐Martínez, L., Vergara-Pulgar, K., & Maccioni, R. B. (2017) · InTech eBooks · doi:10.5772/intechopen.68941 · Cited by 4
Self-citationMitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases
Esteves, A. R., Silva, D. F., Santos, D., Candeias, E., Filipe, F., & Cardoso, S. M. (2018) · InTech eBooks · doi:10.5772/intechopen.72612 · Cited by 4
Sharma, S., Wahl, D., Risen, S. J., Gilberto, V. S., Chatterjee, A., Moreno, J. A., LaRocca, T. J., & Nagpal, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.07.583991 · Cited by 4
Global hotspots and trends of nutritional supplements for sick populations from 2000 to 2024
Shi, C., Liu, H., Fu, T., Li, Y. H., Zhao, H., & Liu, F. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1497207 · Cited by 3
Related Mechanism of Limonene Improves LPS-Induced Neuroinflammation
Jiang, Y., Liu, G., Liu, Q., Zhang, L., Tan, Y., Cen, J., Zhao, Y., & Li, A. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2411.11053 · Cited by 3
Arslan, S. O., Uysal, F., Koç, A., & Çam, S. A. (2025) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1588353 · Cited by 3
Amin, M. A., Zehravi, M., Sweilam, S. H., Shanmugarajan, T. S., Arjun, U. V. N. V., Nagaiyan, M. B., Reddy, S. M., Subash, V., swarnalatha, K. M., Pazhanikumar, A., et al. (2025) · 3 Biotech · doi:10.1007/s13205-025-04470-8 · Cited by 3
Immune Mechanisms in Alzheimer’s Disease: The Role of Toll-Like Receptors Signalling
Sharma, D., Manjunatha, P. M., Babu, T. H., Dhungel, A., Swaraj, S., Janadari, S., Sharma, U., Surendra, V., Taj, N., & Gayathri, S. V. (2024) · Current Pharmacology Reports · doi:10.1007/s40495-024-00376-w · Cited by 3
Hydromethylthionine sustains truncated tau‐dependent inflammation‐lowering effects in mouse brain
Santos, R. X., Lee, S. H., Lofthouse, R. A., Melis, V., Robinson, L., Leith, M., Dreesen, E., Armstrong, P., Vorley, T., Goatman, E. A., et al. (2025) · FEBS Journal · doi:10.1111/febs.70021 · Cited by 3
Non-Steroidal Anti-Inflammatory Drug Use and Essential Tremor
Pan, J., Michalec, M., & Louis, E. D. (2014) · Neuroepidemiology · doi:10.1159/000366424 · Cited by 3
APOE gene region methylation is associated with cognitive performance in middle-aged urban adults
Shen, B., Hernandez, D. G., Chitrala, K. N., Kuczmarski, M. F., Hooten, N. N., Pacheco, N. L., Mode, N. A., Zonderman, A. B., Ezike, N., & Evans, M. K. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.010 · Cited by 3
Santiago-Lopez, A. J., Hovell, C. M., Lee, H., & Kim, Y. (2015) · Biosystems & biorobotics · doi:10.1007/978-3-319-21813-7_13 · Cited by 3
Plant-Derived Antiinflammatory Steroid Analogs for Neuroprotection
Şöhretoğlu, D., & Arroo, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00007-0 · Cited by 3
Lu, M., Ding, N., Wang, X., Cao, J., Jiang, J. H., Gao, Y., & Li, Z. (2019) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2019.03.004 · Cited by 3
Prevention of neurodegenerative disorders by nutraceuticals
Pistollato, F., & Sachana, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00002-1 · Cited by 3
Peripheral Leukocyte Syndecan-3 Is Elevated in Alzheimer’s Disease: Evidence from a Human Study
Hudák, A., Letoha, A., & Letoha, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146587 · Cited by 2
Breaking Down the Core Peptide of Amyloid Beta Protein with Enediyne and Mechanistic Study
Tang, M., Zhang, H., Shen, J., Huang, X., Zhang, X., Wu, T. H., & Hu, A. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.70255 · Cited by 2
Natural Products Targeting Alzheimer’s Disease via NF-κB Pathway: A Review
Hasan, F., Thippamma, K., Kumar, V., Baiseitova, A., Ikram, M. A., & Shah, A. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273397045250922054643 · Cited by 2
Kumar, A., Roy, A., Karaddi, V., Jain, S., Katyal, J., & Gupta, Y. K. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70277 · Cited by 2
do Nascimento, N. B., Farias, H. R., Schons, T., Padilha, A. P. Z., da Costa, M. S., Peres, A. M., Santos¹, L. F. D. S., Dantas, R. M., Ramos, J. M. O., Rodrigues, M. S., et al. (2026) · Neurochemical Research · doi:10.1007/s11064-025-04658-7 · Cited by 2
An Overview of the Effects of Melatonin on Nervous System Diseases
Khalili, Z., Dowom, P. B., Darvishi, M., & Abdal, K. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.7.3.61 · Cited by 2
Rostami, F., Abbasi, Z., & Fereidoni, M. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000701 · Cited by 2
Modeling and control of vascular dementia disease by exact dosing of medicines
Vidhyaa, C. B., Anirudh, P. D. V., Panda, B., Sobana, S., Panda, R. C., & Laskar, J. H. (2023) · International Journal of Robust and Nonlinear Control · doi:10.1002/rnc.7067 · Cited by 2
Qiao, N., & Shao, H. (2024) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2024.2399029 · Cited by 2
Current State of Research on the Mechanisms of Biological Activity of Alginates
Akoulina, E. A., Bonartseva, G. A., Dudun, A. A., Kochevalina, M. Y., Bonartsev, A. P., & Voinova, V. V. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604519 · Cited by 2
Freire, M. A. M., Rocha, G. S., da Costa, I. M., de Oliveira, L. C., Gúzen, F. P., & Cavalcanti, J. R. L. D. P. (2022) · Research Society and Development · doi:10.33448/rsd-v11i6.28861 · Cited by 2
Inflammation in Alzheimer's Disease: Cross-talk between Lipids and Innate Immune Cells of the Brain
Ai, L., & Me, C. (2015) · Cited by 2
Heat Shock Proteins, a Key Modulator of Neuroinflammation in Alzheimer’s Disease
Panchal, K., Bhatt, V., Raval, M., & Tiwari, A. K. (2020) · Heat shock proteins · doi:10.1007/7515_2020_12 · Cited by 2
Role of Neuroinflammation in Neurodegenerative Disorders
Mohan, V., Edamakanti, C. R., & Sharma, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821974-4.00001-7 · Cited by 2
Valipour, M., Davaji, I., Abedi, N., Rajabi, M., Küçükkılınç, T. T., Ayazgök, B., & Irannejad, H. (2019) · PubMed Central · doi:10.22037/ijpr.2019.15567.13181 · Cited by 2
Correction of Fatty Acids Metabolism as Treatment Strategy of Autism
El-Ansary, A. K., & Qasem, H. (2017) · InTech eBooks · doi:10.5772/67488 · Cited by 2
Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions
Zorkina, Y., Abramova, O., Zubkov, E., Gurina, O., & Ushakova, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083560 · Cited by 1
“Nevertheless, despite the promise of targeting neuroinflammation and ROS, it remains unclear whether microglial activation is a primary triggering mechanism or merely a consequence of protein aggregate accumulation [60].”
Olfactory dysfunction in Alzheimer's disease
Strumentova, E. S., Лобзин, С. В., Lobzin, V. Y., Викторовна, Ч. И., Zuev, A. A., Alizade, M., & Zyryanova, A. A. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-22-7-11 · Cited by 1
Asadbegi, M., Komaki, A., Amiri, P., Karimi, S. A., Yaghmaei, P., Ebrahim‐Habibi, A., & Salehi, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110416 · Cited by 2
A Review of the Role of Lymphocytes in Chronic Neuropathic Pain: A Clinical Perspective
McCrory, C. R., Galvin, D., & Galvin, D. (2023) · Medical Research Archives · doi:10.18103/mra.v11i2.3596 · Cited by 1
Neurotoxicity induced by the microbial metabolite β-methylamino-L-alanine: pathways and mechanisms
Candeias, E., Nunes‐Costa, D., Pereira-Santos, A. R., Magalhães, J. D., Melo-Marques, I., Guedes, B., Esteves, A. R., Empadinhas, N., & Cardoso, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00068-3 · Cited by 1
Blossom, V., Ullal, S. D., Rai, R., Chakraborthi, S., Kumar, N. A., Pai, M. M., & Vadgaonkar, R. (2024) · Veterinary World · doi:10.14202/vetworld.2024.2567-2576 · Cited by 1
SENP1: A perspective from immune cells to disease (Review)
Feng, X., Wu, G., & Zeng, Q. (2025) · Oncology Reports · doi:10.3892/or.2025.8947 · Cited by 1
Liao, D., Zhang, M., Yang, Q., Li, T., Cao, Z., Liu, D., Zhang, Z., Li, X., Tian, Z., Li, X., et al. (2026) · Annals of Medicine · doi:10.1080/07853890.2025.2610559 · Cited by 1
Unveiling Nature’s Arsenal: Natural Sources for Drug Discovery in Alzheimer’s Disease
Remya, C., Aiswarya, N., & Dileep, K. V. (2024) · Springer eBooks · doi:10.1007/978-981-99-9183-9_13 · Cited by 1
Prevention of Neurodegenerative Disorders by Nutraceuticals
Pistollato, F., & Sachana, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00002-4 · Cited by 1
A Vaccine Kit for Prevention and Therapy of Alzheimer’s Disease in a Transgenic Mouse Model
Carrera, I., Vigo, C., & Cacabelos, R. (2018) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2018.00004 · Cited by 1
Understanding the Cause of Chronic Traumatic Encephalopathy and Related Dementias
Roukerd, M. R., Stump, A. J., & Hawryluk, G. W. J. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.09.120 · Cited by 1
Neurodegenerative Disease Diagnostics and Therapy of TiO 2 ‐Based Nanoparticles
Gao, X., Qin, J., Jiang, Z., Li, J., & Wu, A. (2020) · Wiley eBooks · doi:10.1002/9783527825431.ch7 · Cited by 1
Estratégias terapêuticas baseadas nos mecanismos fisiopatológicos conhecidos na Doença de Alzheimer
Janeiro, D. I. S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Sarlus, H. (2015) · Figshare
Morales, I., Arata, L., & Maccioni, R. B. (2015)
Self-citationLewy Body Dementia and the Role of Inflammation
Surendranathan, A. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.30607
Alasmari, F. F., Al-Harbi, N. O., Alanazi, M. M., Alasmari, A. F., & Sari, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-7142-4_5
Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease
Talegaonkar, S., Gautam, N., Varshney, V., Sharma, S., & Bhattacharyya, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_13
Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6
Yuan, Q., Wu, Y., Wang, G., Zhou, X., Dong, X., Lou, Z., Li, S., & Wang, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1249349/v1
Dilemma of Glial in Alzheimer’s: A Review of the Role of Glial Cells in Alzheimer’s Disease
Cheng, Y.-X. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5645
The COVID-19–related neuroinflammation model may reveal relevant information on healthy longevity
Luiz, M. V. D. S. J., Silva, J. D. N., Andreotti, D. Z., Mello, P. S. D., Nagy, G. S., Filho, O. P. D. A., & Kawamoto, E. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00008-0
Neha, N., Pinky, P., Dhaka, P., Das, A., Parveen, D., Shaquiquzzaman, M., Alam, M. M., & Parvez, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3766910/v1
Evaluation of Peripheral Inflammatory Activity in Different Types of Dementia
Ataoğlu, E. E. (2024) · Acta Medica Alanya · doi:10.30565/medalanya.1422120
Data to Diagnosis: Harnessing STRING Insights to Unravel the Biomarkers of Alzheimer’s
Rajeev, A., Jose, B. A., Johnson, S., & Koyyappurath, S. (2024) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt61001.2024.10724943
Neuroinflammation-microglia and neurodegeneration
Fathy, A. M., Mostafa, D. M., Sedeq, H. T., Hassan, H. A., Abdullah, H. W., Fawzy, M. M., Abdelgilil, M. E., Ebrahim, Y. A., & El-Sayed, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00005-1
Singh, P., Waghmare, S., Muley, P. P., & Muley, P. A. (2025) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_450_2024
The Role of T Cells in Alzheimer's Disease
Lin, Y., Zhao, H., Meng, D., & Wang, M. (2025) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2025061107
Hassanzadeh, G., Ashouri, S., Kargar, R., Shamosi, A., & Mahakizadeh, S. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10617-x
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085212
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737959
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737980
Ni, W., Niu, Y., Cao, S., Fan, C., Fan, J., Zhu, L., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26157211
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737965
Zhao, C., Kuraji, R., Ye, C., Gao, L., Radaic, A., Kamarajan, P., Taketani, Y., & Kapila, Y. L. (2024) · Figshare · doi:10.6084/m9.figshare.26623867
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737977
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737971
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737962
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085125
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737974
Zhao, C., Kuraji, R., Ye, C., Gao, L., Radaic, A., Kamarajan, P., Taketani, Y., & Kapila, Y. L. (2024) · Figshare · doi:10.6084/m9.figshare.26623864
Ni, W., Niu, Y., Cao, S., Fan, C., Fan, J., Zhu, L., & Wang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26157564
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737983
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737956
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737968
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737986
The origin of Alzheimer’s disease: Prions?
Yang, D., & Wang, M. (2025) · Neurology Letters · doi:10.61882/nl.4.1.76
Nadkarni, S. G., & Dessai, S. N. (2026) · Food and Humanity · doi:10.1016/j.foohum.2026.100993
Loustalot, F. (2015) · theses.fr (ABES) · doi:10.70675/549d8b77z73a1z461fza271zec31f12874d2
Mobilisation de l'acide arachidonique et sensibilité au peptide ß-amyloïde
Thomas, M. H. (2015) · theses.fr (ABES) · doi:10.70675/904987d5zc8c8z4104z95dfz2f7e680d8be3
Karameh, N. (2018) · theses.fr (ABES) · doi:10.70675/b70b7c03z8de8z4ee0z9848z381e95568515
Développement d’un test sanguin pour le dépistage de la maladie d’Alzheimer
Torres, F. D. (2022) · theses.fr (ABES) · doi:10.70675/afbb97a5z1636z46abz844czb340616aeda1
Luo, A., Yang, Q., Zhang, Z., Yang, Y., Li, X., Deng, Y., He, L., & Zhou, M. (2026) · Revue du Rhumatisme · doi:10.1016/j.rhum.2026.05.006
Sosa, W., Camargo, L., & Fregni, F. (2026) · Biomedicines · doi:10.3390/biomedicines14051165
A mechanistic framework linking the oral microbiome to Alzheimer's disease through neuroinflammation
Evers, M. J. A. P., Krom, B. P., & de Jongh, C. A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261456324
Circulating biochemical signatures of neurodegeneration in Alzheimer’s disease
Eliazer, G. R., & Kandasamy, M. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.06.004
Murugan, A. K. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153500
Mosquera-Heredia, M. I., Vidal, O. M., Barceló, E., Morales, L. C., Silvera-Redondo, C. A., Bolívar, D. A., Allegri, R., Arcos‐Burgos, M., Garavito, P., & Velez, J. I. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261470430
Giffin, K. A., Puranik, N., Bustamante, A. C., Padilla, M., Zeng, Z., Randolph, G., Wheaton, L., Moore, S. J., Newstead, M. W., Denstaedt, S. J., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101309
Therapeutic potential of Withania somnifera in alleviating neurodegenerative diseases
Kumar, N., Kour, M., Sharma, S., & Kumar, D. (2026) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-026-00918-4
Piplani, M., Thakur, S., Kumar, P., Garg, S. S., Goyal, A., & Goyal, P. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3483
Metadata
- Authors
- Morales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B.
- Affiliations
- University of Chile (CL)
- Corresponding author
- Maccioni, Ricardo B.
- ORCID
- Maccioni, Ricardo B.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-04-22
- Volume
- 8
- Pages
- 112-112
- ISSN
- 1662-5102 (ISSN-L)
- PMC
- PMC4001039
- OpenAlex
- W2109984042
- Cited by
- 490
- References
- 85
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 43 · 2023: 38 · 2022: 45 · 2021: 40 · 2020: 50 · 2019: 48 · 2018: 45 · 2017: 50 · 2016: 25 · 2015: 50 · 2014: 14
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Corporación de Fomento de la Producción
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, neuroimmunomodulation, microglia, astrocytes, innate immunity, anti-inflammatory agents, tau oligomers, amyloid-beta, oxidative stress, iron, curcumin, neurodegeneration, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review